Regenerative medicine and cell therapies hold the promise of revolutionizing treatments for diseases such as cancer, diabetes and stroke. But key questions remain and researchers face significant challenges in moving discoveries from laboratory to clinic. To realize the extraordinary potential of this field, we need a new approach.
Medicine by Design harnesses the exceptional expertise at the University of Toronto and its affiliated hospitals at the convergence of physical and life sciences, engineering, mathematics and medicine to undertake transformative research in regenerative medicine and cell therapy. It fosters unique multidisciplinary collaborations and uses engineering design principles and quantitative biological modelling to nurture innovative environments where breakthroughs emerge. Through strategic investments and partnerships, Medicine by Design is powering Toronto’s burgeoning biomedical ecosystem, strengthening Canada as a global centre for regenerative medicine and accelerating cures.
Medicine by Design is made possible in part thanks to a grant from the Canada First Research Excellence Fund.